Adverum Biotechnologies (ADVM) Q2 2025 Earnings

14MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-2.25
-1.8
-1.34
-0.89

Details

Expected EPS
-1.94
Actual EPS
-2.25
Surprise EPS
-0.31
Surprise Percent
+15.98%

Description

Adverum Biotechnologies (ADVM) has reported earnings of -2.25 per share for Q2 2025.

0 Comments

Share your thoughts